From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves Roche's cotellic treatment for melanoma

from The Wall Street Journal

The U.S. Food and Drug Administration said it has approved Cotellic, a drug produced by Swiss biotech company Roche, for use in combination with the vemurafenib medication as a treatment for advanced melanoma. The drugs are intended to target the illness after it has spread to other parts of the body or can’t be removed by surgery. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063